BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 16052597)

  • 1. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
    Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
    Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
    Jacobsson LT; Turesson C; Hanson RL; Pillemer S; Sievers ML; Pettitt DJ; Bennett PH; Knowler WC
    Arthritis Rheum; 2001 May; 44(5):1170-6. PubMed ID: 11352251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis.
    Mattey DL; Glossop JR; Nixon NB; Dawes PT
    Arthritis Rheum; 2007 Dec; 56(12):3940-8. PubMed ID: 18050238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and predictors of mortality in rheumatoid arthritis--a role for mannose-binding lectin?
    Troelsen LN; Garred P; Jacobsen S
    J Rheumatol; 2010 Mar; 37(3):536-43. PubMed ID: 20110521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline.
    Wiles NJ; Dunn G; Barrett EM; Harrison BJ; Silman AJ; Symmons DP
    J Rheumatol; 2000 Oct; 27(10):2360-6. PubMed ID: 11036830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
    Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
    Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
    Petersson U; Ostgren CJ; Brudin L; Nilsson PM
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: an independent predictor of cardiovascular disease in Aboriginal Australians.
    Wang Z; Hoy WE
    Aust N Z J Public Health; 2010 Jul; 34 Suppl 1():S25-9. PubMed ID: 20618287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
    Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
    Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation biomarkers and near-term death in older men.
    Jenny NS; Yanez ND; Psaty BM; Kuller LH; Hirsch CH; Tracy RP
    Am J Epidemiol; 2007 Mar; 165(6):684-95. PubMed ID: 17215383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study.
    Okin PM; Roman MJ; Best LG; Lee ET; Galloway JM; Howard BV; Devereux RB
    J Am Coll Cardiol; 2005 Jun; 45(11):1787-93. PubMed ID: 15936607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
    Best LG; Zhang Y; Lee ET; Yeh JL; Cowan L; Palmieri V; Roman M; Devereux RB; Fabsitz RR; Tracy RP; Robbins D; Davidson M; Ahmed A; Howard BV
    Circulation; 2005 Aug; 112(9):1289-95. PubMed ID: 16116058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular death in rheumatoid arthritis: a population-based study.
    Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.